Insulin Resistance Assessment and Management

Introduction to Insulin Resistance

• The American Heart Association recommends that the hyperinsulinemic-euglycemic clamp is the gold standard for measuring insulin sensitivity, but it remains a research tool only due to its complexity, cost, and time requirements 1, 2

Clinical Assessment of Insulin Resistance

• The American College of Cardiology suggests using fasting plasma glucose and fasting insulin levels instead of the clamp for routine clinical assessment of insulin resistance 1, 2
• Fasting insulin levels can be interpreted as follows: normal (<15 mU/L), borderline high (15-20 mU/L), and high (>20 mU/L), indicating insulin resistance 1, 2

Target Population for Screening

• The American Diabetes Association recommends screening children and adults with overweight/obesity, family history of type 2 diabetes, high-risk ethnicity, and clinical signs such as acanthosis nigricans, hypertension, dyslipidemia, or polycystic ovary syndrome for insulin resistance 1, 2

Comprehensive Evaluation

• The American Heart Association recommends a comprehensive evaluation beyond glucose, including fasting plasma glucose, HbA1c, lipid panel, blood pressure measurement, and BMI calculation 1, 2, 3

Therapeutic Approach

• The American Diabetes Association recommends prioritizing lifestyle modification and considering metformin as first-line pharmacotherapy once insulin resistance is identified 3, 4
• Lifestyle interventions, including weight reduction, regular physical activity, dietary modification, and avoiding glucose variability, can improve insulin sensitivity 4, 5

Glycemic Targets

• The American Diabetes Association recommends glycemic targets of HbA1c <7.0% for most patients, with more stringent targets (6.0-6.5%) for selected patients and less stringent targets (7.5-8.0%) for patients with history of severe hypoglycemia or advanced complications 3, 4

Special Populations

• The Endocrine Society suggests that insulin resistance develops even in type 1 diabetes due to exogenous insulin delivery, and targeting insulin resistance may reduce complications 7
• The American Academy of Pediatrics recommends focusing on prevention through early detection and lifestyle modification in pediatric patients, with subspecialist consultation recommended for complex cases 1, 2